Task: Answer the multiple choice question.
Question: Which compound has a -36.182% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. CC1CCN(S(=O)(=O)c2ccc3c(c2)N(CC(=O)NCCCN2CCCC(C)C2)C(=O)CS3)CC1
b. Cc1ccc(-c2cn(-c3ccccc3)c(SCC(N)=O)n2)cc1C
c. CCOc1ccc(NC(=O)C2CCCN2C(=O)OCc2ccccc2)cc1
Answer: b. Cc1ccc(-c2cn(-c3ccccc3)c(SCC(N)=O)n2)cc1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(-c2cn(-c3ccccc3)c(SCC(N)=O)n2)cc1C
Cc1ccc(-c2cn(-c3ccccc3)c(SCC(N)=O)n2)cc1C
2-[4-(3,4-dimethylphenyl)-1-phenylimidazol-2-yl]sulfanylacetamide